Completed OBSERVATIONAL NCT03027232

Control of Leukocyte Function

Sponsor: Beth Israel Deaconess Medical Center

Interventions No intervention (drugs) will be given. Purpose: collecting blood for in vitro studies

Updated 10 times since 2017 Last updated: Apr 26, 2018 Started: Jan 31, 2007 Primary completion: Dec 15, 2017 Completion: Dec 15, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Inflammation, Brain, this trial is completed. The trial is conducted by Beth Israel Deaconess Medical Center and has accumulated 10 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed

Status: Recruiting → Completed
Apr 2018 — May 2018 [monthly]

Recruiting

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Recruiting NA
Feb 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Deaconess Medical Center

Data source: Beth Israel Deaconess Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States